Ligand Pharmaceuticals, Inc. (LGND)
183.09
-0.94
(-0.51%)
USD |
NASDAQ |
Dec 11, 16:00
183.09
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap: 3.604B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 245.75B |
| Inspire Medical Systems, Inc. | 3.991B |
| Alnylam Pharmaceuticals, Inc. | 54.51B |
| Johnson & Johnson | 505.98B |
| AbbVie, Inc. | 395.86B |
Market Cap Related Metrics
| PE Ratio | 88.12 |
| PS Ratio | 14.34 |
| Price to Book Value | 3.793 |
| Price to Free Cash Flow | 176.37 |
| Price | 183.09 |
| Earnings Yield | 1.13% |
| Operating PE Ratio | 124.91 |
| Normalized PE Ratio | 811.57 |